Literature DB >> 11995485

Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy.

Luca Aldrighetti1, Marcella Arru, Enzo Angeli, Massimo Venturini, Marco Salvioni, Monica Ronzoni, Roberto Caterini, Gianfranco Ferla.   

Abstract

BACKGROUND/AIMS: Intra-arterial hepatic chemotherapy based on floxuridine infusion is an effective treatment for hepatic metastases from colorectal cancer. The aim of the present study is the comparative analysis of surgical and percutaneous transaxillary approaches to implant a catheter into the hepatic artery for intra-arterial hepatic chemotherapy with floxuridine.
METHODOLOGY: Fifty-six patients received an arterial device for intra-arterial hepatic chemotherapy. Twenty-eight patients (LPT group) underwent laparotomy to implant the catheter into the hepatic artery, the other 28 patients (PCT group) received a percutaneous catheter into the hepatic artery through a transaxillary percutaneous access. Safety and efficacy of surgical and percutaneous transaxillary approaches were comparatively analyzed in terms of number of intra-arterial hepatic chemotherapy cycles administered, device-related complications causing suppression of intra-arterial hepatic chemotherapy, and biological costs of the procedures.
RESULTS: Mean postoperative hospitalization was 8.2 +/- 2.2 days in the LPT group and 1.8 +/- 0.7 days in the PCT group (P < 0.0001), while mean analgesic requirements were 9.7 +/- 3.2 doses in the LPT group and 2 +/- 0.9 doses in the PCT group (P < 0.0001). Mean number of intra-arterial hepatic chemotherapy cycles administered was 6.5 +/- 4.2 in the LPT group and 4.3 +/- 3.4 in the PCT group (P = 0.038). The overall incidence of device-related complications causing suppression of intra-arterial hepatic chemotherapy was 42.7% in the PCT group and 7.1% in the LPT group (P = 0.005).
CONCLUSIONS: Surgical implantation is still recommended when laparotomy has to be performed for other contextual procedures, such as colorectal or hepatic resection, while percutaneous transaxillary catheter placement is indicated for palliative or neoadjuvant intra-arterial hepatic chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11995485

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  9 in total

1.  Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases.

Authors:  Carlo Pulitanò; Luca Aldrighetti; Marcella Arru; Giordano Vitali; Monica Ronzoni; Marco Catena; Renato Finazzi; Eugenio Villa; Gianfranco Ferla
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

Review 2.  Hepatic arterial infusional chemotherapy in the management of colorectal cancer liver metastases.

Authors:  Alexandre Doussot; Nancy E Kemeny; Michael I D'Angelica
Journal:  Hepat Oncol       Date:  2015-07-27

3.  Laparoscopic hepatic artery catheterization for regional chemotherapy: is this the best current option for liver metastatic disease?

Authors:  M Franklin; J Trevino; H Hernandez-Oaknin; T Fisher; K Berghoff
Journal:  Surg Endosc       Date:  2006-02-27       Impact factor: 4.584

Review 4.  Current treatment for liver metastases from colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

5.  Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang; An-Long Zhu; Lin-Feng Wu; Shu-Yi Qi; Da-Xun Piao
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

6.  Interventional management of gastroduodenal lesions complicating intra-arterial hepatic chemotherapy.

Authors:  Stefania Proietti; Thierry De Baere; Bertrand Bessoud; Francesco Doenz; Salah Dine Qanadli; Pierre Schnyder; Alban Denys
Journal:  Eur Radiol       Date:  2007-01-12       Impact factor: 7.034

7.  Use of an antagonist of HMGB1 in mice affected by malignant mesothelioma: a preliminary ultrasound and optical imaging study.

Authors:  Massimo Venturini; Rosanna Mezzapelle; Salvatore La Marca; Laura Perani; Antonello Spinelli; Luca Crippa; Anna Colarieti; Anna Palmisano; Paolo Marra; Andrea Coppola; Federico Fontana; Giulio Carcano; Carlo Tacchetti; Marco Bianchi; Antonio Esposito; Massimo P Crippa
Journal:  Eur Radiol Exp       Date:  2022-02-08

8.  Editorial of Special Issue "Embolization Techniques: State of the Art and Future Perspectives".

Authors:  Massimo Venturini; Filippo Piacentino; Andrea Coppola; Federico Fontana
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

9.  Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients.

Authors:  Stefano Bacchetti; Enricomaria Pasqual; Elena Crozzolo; Alessandra Pellarin; Pier Paolo Cagol
Journal:  Med Devices (Auckl)       Date:  2009-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.